Category: Federal Forum Posters
Purpose: The primary purpose of this study is to determine if automatic insulin refills is a large contributor to the overall cost of insulin at CTVHCS. If the automatic refill process is found to be a high contributor to total costs, then will improve the current process by creating a date driven process for refills.
Methods: Will utilize the VISN 17 Datamart Active Outpatient Prescription tool to pull all outpatient insulin prescriptions at CTVHCS over a specified time frame from all provider types, including clinical pharmacy specialists, physicians, nurse practitioners, and physician assistants.
Will pull random sample of 25-50 unique patients using either Novolog or insulin glargine who have received an insulin dose adjustment within CTVHCS over time frame, since these insulins are current most commonly filled at CTVHCS. Will determine time frame once unique number of patients is met after screening.
Will compare refill based adherence of patients who received automatic insulin refill upon dose adjustment versus patients whose provider circumvented automatic refill process after dose adjustment by either changing date refilled or leaving comment to verifying pharmacist to change refill date.
Will review cost per refill per patient, and then multiply by medication possession ratio (MPR) to determine the extra cost incurred by the automatic refills. Will multiply this extra cost by average number of automatic refills per patient by total number of patients in study time period with automatic insulin refills. Will then extrapolate data to estimate cost over year time period.
Results: not applicable
Conclusion: not applicable
Chelsey Roscoe– PGY1 Pharmacy Resident, Central Texas Veterans Health Care System, Austin, TX